跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
吳 天元
副教授
,
臨床藥學學科
https://orcid.org/0000-0002-5205-4567
電子郵件
tyuanwu
tmu.edu
tw
h-index
2159
引文
17
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2026
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(46)
類似的個人檔案
(5)
指紋
查看啟用 Tien-Yuan Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Transcription Factor Nrf2
100%
Malignant Neoplasm
75%
Antioxidant
51%
Pharmacodynamics
42%
Cohort Study
37%
Enzymes
33%
Phytochemical
31%
Prostate Cancer
31%
Pharmacokinetics
28%
Tangeretin
21%
Messenger RNA
18%
Sulforaphane
18%
Prothrombin
16%
Breast Cancer
15%
Retrospective Study
14%
Adenocarcinoma
14%
Hyperlipidemia
14%
Proton Pump Inhibitor
14%
3 Indolemethanol
14%
Non Small Cell Lung Cancer
14%
Epidermal Growth Factor Receptor Kinase Inhibitor
14%
Lipopolysaccharide-Induced Inflammation
14%
Syzygium
14%
Pharmacogenomics
14%
Chemopreventive Agents
13%
Malus pumila
12%
Rat
12%
Carcinogenesis
11%
Drug Metabolizing Enzyme
11%
Diseases
10%
Citrus
9%
Anticarcinogen
9%
Lipid
8%
Antioxidant Capacity
8%
Anti-Inflammatory Drug
8%
Infection
8%
Isothiocyanate
8%
Pharmacodynamic Modeling
8%
Chemotherapy Regimens
7%
Prostate Tumor
7%
Hepatotoxicity
7%
Reactive Oxygen Metabolite
7%
Tocopherol
7%
Indole Derivative
7%
Hydrogen Peroxide
7%
Lotus (Genus)
7%
Skin Cancer
7%
Hyperthyroidism
7%
Mortality Rate
7%
Rikkunshito
7%
Biochemistry, Genetics and Molecular Biology
Transcription Factor Nrf2
59%
Promoter Region
34%
Phytochemical
34%
Gene Expression
27%
Demethylation
22%
LNCaP
21%
Epigenomics
21%
Epigenetics
21%
Carcinogenesis
20%
Methylation
15%
Cohort Study
14%
P21
14%
Cell Proliferation
14%
Oxidative Stress
13%
DNA Methylation
12%
Transgenics
12%
Epigenetic Modification
11%
Epigenetic Mechanism
9%
Reprogramming
9%
Citrus
8%
Cell Transformation
8%
Enzyme
8%
Protein Expression
8%
DNA Methyltransferase
7%
DNA Hypomethylation
7%
Pharmacogenomics
7%
Pharmacodynamics
7%
Pharmacogenetics
7%
Sulforaphane
7%
Angelica Sinensis
7%
Hyperlipidemia
7%
Nrf2 Pathway
7%
Transactivation
7%
Chrysanthemum
7%
C57BL 6 Mouse
7%
Cancer Stem Cell
7%
Maturity Onset Diabetes of the Young
7%
Retrospective Study
7%
Real-World Evidence
7%
Peroxisome Proliferator-Activated Receptor
7%
Lotus (Genus)
7%
Histone Deacetylase
6%
Anti-Inflammatory
5%
Messenger RNA
5%
Medicine and Dentistry
Gene Expression
31%
Cohort Analysis
21%
Hyperlipidemia
21%
In Vitro
21%
Retrospective Cohort Study
18%
Malignant Neoplasm
14%
Maturity Onset Diabetes of the Young
14%
Antidepressant Medication
13%
Lipogenesis
10%
Patient with Depression
9%
Prostate Cancer
8%
Hazard Ratio
8%
Transcription Factor Nrf2
7%
Chemoprevention
7%
Tocopherol
7%
Phytochemical
7%
Carcinogenesis
7%
Epigenomics
7%
Lipid Homeostasis
7%
Cancer Stem Cell
7%
Ulcer
7%
Infusion
7%
Tangeretin
7%
Traditional Chinese Medicine
7%
Proton-Pump Inhibitor
7%
P21
7%
Cell Proliferation
7%
Urate
7%
Gout
7%
Epilepsy
7%
Erythrocyte
7%
Transactivation
7%
Antipsychotic
7%
Schizophrenia
7%
Cohort Studies
7%
Health Care Cost
7%
Anticonvulsant
7%
Peroxisome Proliferator Activated Receptor
7%
Cardiovascular Disease
6%
Mortality Rate
5%
Proportional Hazards Model
5%
